Stock Updates

Today’s Top Gainers in the Market Valeant Pharmaceuticals International, Inc. (NYSE:VRX) from Healthcare

Today’s top gainers include the company Valeant Pharmaceuticals International, Inc. (NYSE:VRX) which is in the industry Drug Delivery, gaining -0.84% today. In the last week its performance is 7.27%, and 8.48% for the past quarter. Currently, Valeant Pharmaceuticals International, Inc., VRX has a target price of 44.39, so today’s gain of -0.84% is a significant step towards its target price. The GAP today is therefore 1.25%.

Valeant Pharmaceuticals International, Inc. (NYSE:VRX), has a market cap of 10618.78, and is based in Canada. Insider ownership is at 2.30%, and institutional ownership is 66.80%.

At the current price of 30.83, it has a dividend yield of *TBA, and its target price is 44.39. This is with a profit margin of -9.60%, and total debt/equity of 5.87. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has a P/E of *TBA, as well as a forward P/E of 4.

With a current EPS of -2.86, and a forecasted EPS growth for next year at 17.94%,Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has had a EPS growth for the past five years at 4.40%. For the next five years EPS growth is projected to be 11.07%.

Performance for the year is -86.88%. Since its IPO date on 3/30/1994, the total performance to date is -69.67%.

Volume today for Valeant Pharmaceuticals International, Inc. (NYSE:VRX), is 23682024, while its average volume is 30060.72. Whilst the total gain today was -0.84%, it did have a day high of -5.83%.

Volatility for this week has been at 5.74%, and 5.88% for the month. The 52-week low for Valeant Pharmaceuticals International, Inc., VRX has been 66.20%, while the 52-week-high has reached -87.46%.

Looking at its return of investments, which is 3.70%, and its return on assets is -2.00%. Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has an operating margin of 7.70%. With a sales growth of -68.30% quarter over quarter. Bearing in mind that Valeant Pharmaceuticals International, Inc., VRX is in the sector Healthcare, its long-term debt/equity is 5.81, and has a current ratio of 1.4 and 1.1 for quick ratio.

So what is the value of Valeant Pharmaceuticals International, Inc.? Well its PEG is *TBA, and the P/S is 1.03, along with a P/B of 2.01. Meanwhile it has a p/cash of 12.46.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment